Irenic Capital Management’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.8M	Hold	2,760,948	–	–	4.06%	8
2025 Q4	$51.7M	Hold	2,760,948	–	–	6.77%	4
2025 Q3	$40.3M	Hold	2,760,948	–	–	7.92%	6
2025 Q2	$30.5M	Hold	2,760,948	–	–	6.7%	7
2025 Q1	$24.7M	Hold	2,760,948	–	–	5.4%	9
2024 Q4	$26M	Hold	2,760,948	–	–	3.96%	14
2024 Q3	$22.3M	Hold	2,760,948	–	–	3.91%	13
2024 Q2	$23.4M	Hold	2,760,948	–	–	5.68%	9
2024 Q1	$24.8M	Hold	2,760,948	–	–	6.34%	7
2023 Q4	$31M	Hold	2,760,948	–	–	6.72%	5
2023 Q3	$23.8M	Hold	2,760,948	–	–	7.31%	3
2023 Q2	$28.6M	Sell	2,760,948 -3,100	-0.1%	-$34.2K	9.81%	4
2023 Q1	$30M	Buy	2,764,048 +1,063,111	+63%	+$11.2M	12.47%	4
2022 Q4	$19.1M	Buy	+1,700,937	New	+$17.9M	10.13%	3